Indeed, Smad3 can be activated by both TGF-β-dependent and independent mechanisms including Ang II, advanced end products (AGE), and CRP under various disease conditions such as hypertension and diabetes 125-127. The gene discussed is AGT; the disease is hypertensive disorder.